These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11738746)

  • 1. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation.
    Munoz FM; Englund JA; Cheesman CC; Maccato ML; Pinell PM; Nahm MH; Mason EO; Kozinetz CA; Thompson RA; Glezen WP
    Vaccine; 2001 Dec; 20(5-6):826-37. PubMed ID: 11738746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine.
    Shahid NS; Steinhoff MC; Hoque SS; Begum T; Thompson C; Siber GR
    Lancet; 1995 Nov; 346(8985):1252-7. PubMed ID: 7475716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
    Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination.
    Holmlund E; Nohynek H; Quiambao B; Ollgren J; Käyhty H
    Vaccine; 2011 Jun; 29(28):4565-75. PubMed ID: 21550374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy.
    Obaro SK; Deubzer HE; Newman VO; Adegbola RA; Greenwood BM; Henderson DC
    Pediatr Infect Dis J; 2004 Nov; 23(11):1023-9. PubMed ID: 15545857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
    Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal non-typeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, controlled study.
    Lalwani S; Chatterjee S; Chhatwal J; Verghese VP; Mehta S; Shafi F; Borys D; Moreira M; Schuerman L
    Hum Vaccin Immunother; 2012 May; 8(5):612-22. PubMed ID: 22634448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Hernández-Delgado L; Lavalle-Villalobos A; Casas-Muñoz A; Cervantes-Apolinar Y; Moreira M; Schuerman L
    Hum Vaccin; 2011 Nov; 7(11):1137-45. PubMed ID: 22048109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population.
    Carvalho BT; Carneiro-Sampaio MM; Solé D; Naspitz C; Leiva LE; Sorensen RU
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):50-4. PubMed ID: 9874663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
    Dagan R; Givon-Lavi N; Porat N; Greenberg D
    Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies.
    Quiambao BP; Nohynek HM; Käyhty H; Ollgren JP; Gozum LS; Gepanayao CP; Soriano VC; Makela PH
    Vaccine; 2007 May; 25(22):4470-7. PubMed ID: 17442467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal nasopharyngeal carriage among infants born to human immunodeficiency virus-infected mothers immunized with pneumococcal polysaccharide vaccine during gestation.
    Almeida Vde C; Negrini BV; Cervi MC; Isaac Mde L; Mussi-Pinhata MM
    Pediatr Infect Dis J; 2011 Jun; 30(6):466-70. PubMed ID: 21200361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine.
    Simell B; Nurkka A; Lahdenkari M; Givon-Lavi N; Käyhty H; Dagan R; Jokinen J
    Clin Vaccine Immunol; 2012 Jan; 19(1):96-9. PubMed ID: 22072724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.
    Rennels MB; Edwards KM; Keyserling HL; Reisinger KS; Hogerman DA; Madore DV; Chang I; Paradiso PR; Malinoski FJ; Kimura A
    Pediatrics; 1998 Apr; 101(4 Pt 1):604-11. PubMed ID: 9521941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Immunization with Pneumococcal Polysaccharide Vaccine: Persistence of Maternal Antibodies in Infants.
    Berezin EN; Lopes CC; Cardoso MRA
    J Trop Pediatr; 2017 Apr; 63(2):118-123. PubMed ID: 27645456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study.
    Dicko A; Dicko Y; Barry A; Sidibe Y; Mahamar A; Santara G; Dolo A; Diallo A; Doumbo O; Shafi F; François N; Yarzabal JP; Strezova A; Borys D; Schuerman L
    Hum Vaccin Immunother; 2015; 11(9):2207-14. PubMed ID: 26020101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants.
    Almeida Vde C; Mussi-Pinhata MM; De Souza CB; Kubo CA; Martinez EZ; Carneiro-Sampaio MM; Duarte G
    Vaccine; 2009 Jun; 27(29):3856-61. PubMed ID: 19443091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.